Shares of Discovery Laboratories Inc. (NASDAQ:WINT) gapped up prior to trading on Friday . The stock had previously closed at $2.64, but opened at $2.65. Discovery Laboratories shares last traded at $3.07, with a volume of 2,013,497 shares changing hands.

Several analysts recently commented on WINT shares. HC Wainwright reiterated a “buy” rating on shares of Discovery Laboratories in a report on Friday, May 20th. Zacks Investment Research upgraded Discovery Laboratories from a “hold” rating to a “buy” rating and set a $2.25 target price on the stock in a report on Thursday, June 23rd.

The firm’s market cap is $24.26 million. The stock has a 50-day moving average price of $2.02 and a 200-day moving average price of $2.19.

Discovery Laboratories (NASDAQ:WINT) last released its quarterly earnings results on Wednesday, August 10th. The company reported ($1.29) earnings per share for the quarter, beating the consensus estimate of ($1.64) by $0.35. On average, equities analysts anticipate that Discovery Laboratories Inc. will post ($5.87) earnings per share for the current fiscal year.

Windtree Therapeutics, Inc, formerly Discovery Laboratories, Inc, is a biotechnology company. The Company is focused on developing KL4 surfactant therapies for respiratory diseases and other potential applications. The Company operates through the research and development of products focused on surfactant therapies for respiratory disorders and diseases, and the manufacture and commercial sales of approved products segment.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with's FREE daily email newsletter.